Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
Interferon γ secretion by activated T cells alters the immunopeptidome landscape of cancer cells, enriching for W>F substitutant epitopes. Champagne et al. demonstrate that these induced neoepitopes are widespread, shared between cancer types, and are amenable to adoptive T cell therapy to enhance the efficiency of conventional immunotherapeutic approaches.